Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M34.5Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-0.0
Enterprise Value $M-31.7EPS (TTM) $-1.8Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book0.610-y EBITDA Growth Rate %--Quick Ratio12.8Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio12.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-37.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-39.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M15.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NVLS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
NVLSJulian Robertson 2015-09-30 Buy 1.13%$12.74 - $20.16
$ 2.22-86%New holding650,915
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVLS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

NVLS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rodman David MalcomExec Vice President and CMO 2017-01-04Sell6,687$2.27-2.2view
Carruthers R MichaelExec Vice President / CFO 2016-12-02Buy24,000$2.096.22view
Rodman David MalcomExec Vice President and CMO 2016-10-04Sell5,820$7.96-72.11view
Rodman David MalcomExec Vice President and CMO 2016-07-05Sell5,950$4.66-52.36view
Congleton JonPresident and CEO 2016-06-16Buy5,000$3.87-42.64view
Congleton JonPresident and CEO 2016-03-24Buy5,000$4.22-47.39view
Congleton JonPresident and CEO 2016-03-22Buy5,000$4.38-49.32view
Congleton JonPresident and CEO 2015-12-11Buy5,000$8.1-72.59view
CONWAY ROBERT EDirector 2015-12-09Buy10,000$8.1-72.59view
Flynn James E 2015-06-23Buy250,000$14-84.14view

Quarterly/Annual Reports about NVLS:

News about NVLS:

Articles On GuruFocus.com
No related article found.

More From Other Websites
Here’s What Happens Now At Nivalis Therapeutics Inc (NVLS) Jan 16 2017
Nivalis to lay off CEO and 80% of staff as part of restructuring Jan 12 2017
NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities,... Jan 12 2017
Nivalis Therapeutics Announces Corporate Restructuring Jan 12 2017
Colorado biotech to streamline operations, explore alternatives after clinical trial failure Jan 04 2017
NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 04 2017
Nivalis Therapeutics Announces Review of Strategic Alternatives Jan 03 2017
Nivalis Therapeutics Announces Review of Strategic Alternatives Jan 03 2017
New Strong Buy Stocks for December 30th Dec 30 2016
These 5 Stocks Under $10 Could Make You a Lot of Money Dec 22 2016
How Achaogen Inc (AKAO) Stacks Up Against Its Peers Dec 19 2016
Should You Buy Nivalis Therapeutics Inc (NVLS)? Dec 07 2016
6 Companies That Destroyed Shareholders Last Week Dec 03 2016
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda Dec 02 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nivalis... Nov 29 2016
Biotech Movers And Shakers: Nivalis Therapeutics Inc (NVLS) And Amicus Therapeutics, Inc. (FOLD) Nov 29 2016
Fitbit, Vodafone Sink into Tuesday’s 52-Week Low Club Nov 29 2016
Nivalis Therapeutics Crumbles on Failed Mid-Stage Trial Nov 29 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving... Nov 29 2016
Nivalis Cystic Fibrosis Fails Phase 2 Study (NVLS) Nov 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)